| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Monte Rosa Therapeutics Inc. Common Stock (NASDAQ: GLUE)
GLUE Technical Analysis
5
| As on 8th Jan 2026 GLUE STOCK Price closed @ 25.31 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 6.08 & Strong Buy for SHORT-TERM with Stoploss of 7.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GLUESTOCK Price
| Open | 23.36 | Change | Price | % |
| High | 25.77 | 1 Day | 2.03 | 8.72 |
| Low | 22.77 | 1 Week | 9.19 | 57.01 |
| Close | 25.31 | 1 Month | 9.55 | 60.60 |
| Volume | 3512738 | 1 Year | 14.95 | 144.31 |
| 52 Week High 25.31 | 52 Week Low 3.70 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 185.04 | -2.15% |
| OCG | 0.02 | 0.00% |
| ONDS | 14.01 | 15.02% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| SXTC | 1.25 | -37.50% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GLUE Daily Charts |
GLUE Intraday Charts |
Whats New @ Bazaartrend |
GLUE Free Analysis |
|
|
GLUE Important Levels Intraday
| RESISTANCE | 31.09 |
| RESISTANCE | 29.24 |
| RESISTANCE | 28.09 |
| RESISTANCE | 26.95 |
| SUPPORT | 23.68 |
| SUPPORT | 22.53 |
| SUPPORT | 21.38 |
| SUPPORT | 19.53 |
GLUE Forecast January 2026
| 4th UP Forecast | 34.35 |
| 3rd UP Forecast | 31.45 |
| 2nd UP Forecast | 29.66 |
| 1st UP Forecast | 27.87 |
| 1st DOWN Forecast | 22.75 |
| 2nd DOWN Forecast | 20.96 |
| 3rd DOWN Forecast | 19.17 |
| 4th DOWN Forecast | 16.27 |
GLUE Weekly Forecast
| 4th UP Forecast | 31.73 |
| 3rd UP Forecast | 29.67 |
| 2nd UP Forecast | 28.40 |
| 1st UP Forecast | 27.12 |
| 1st DOWN Forecast | 23.50 |
| 2nd DOWN Forecast | 22.22 |
| 3rd DOWN Forecast | 20.95 |
| 4th DOWN Forecast | 18.89 |
GLUE Forecast2026
| 4th UP Forecast | 68.22 |
| 3rd UP Forecast | 54.46 |
| 2nd UP Forecast | 45.95 |
| 1st UP Forecast | 37.45 |
| 1st DOWN Forecast | 13.17 |
| 2nd DOWN Forecast | 4.67 |
| 3rd DOWN Forecast | -3.84 |
| 4th DOWN Forecast | -17.6 |
Monte Rosa Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : GLUE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GLUE Business Profile
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is based in Boston, Massachusetts. Address: 645 Summer Street, Boston, MA, United States, 02210
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service